Skip to content

Soluble fibre metabolites in healthy adults- Part B

A randomised crossover trial investigating the plasma short chain fatty acid (SCFA) yield of two different soluble fibre supplements in healthy adult males and females

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000708257
Acronym
OLI- Part B
Enrollment
15
Registered
2018-05-01
Start date
2018-05-10
Completion date
2018-06-18
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Soluble fibre is a source of plasma short chain fatty acids (SCFA), which are known to have antiinflammatory properties. This study will investigate the plasma short chain fatty acid (SCFA) yield over 10 hours following consumption of two different oligosaccharide blends in healthy adult males and females. This information will be used in the design of future clinical intervention trials.

Interventions

This is a double-blinded, randomised, 2-way crossover trial. Participants are required to attend 2 clinic visits. At each clinic visit participants will be randomly allocated to consume one of 2 treatments (2 different soluble fibre formulations, containing 12g of different types of oligosaccharides), plus 2 slices of white bread and 250ml water (room temperature). Study meals will be consumed in random order, with a minimum one-week washout period between clinic visits. Adherence to the interve

This is a double-blinded, randomised, 2-way crossover trial. Participants are required to attend 2 clinic visits. At each clinic visit participants will be randomly allocated to consume one of 2 treatments (2 different soluble fibre formulations, containing 12g of different types of oligosaccharides), plus 2 slices of white bread and 250ml water (room temperature). Study meals will be consumed in random order, with a minimum one-week washout period between clinic visits. Adherence to the intervention will be monitored by direct observation by study personnel. In the two days prior to the scheduled appointments, participants will consume fibre-controlled background diet. This will include consumption of no more than 3 serves of fruits and vegetables combined per day, and avoidance of other high soluble fibre content foods including oats, legumes (kidney, navy, lima, baked beans), wholegrain bread and cereal products. Participants will be provided with a standardised non-fermentable evening meal (lasagna), which they will be asked to consume the night before each of their scheduled appointments. They will also be asked to fast for 12-hours prior to the clinic visit.

Sponsors

Professor Lisa Wood
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Males and Females Aged 18+ years

Exclusion criteria

Body mass index (BMI)>= 3okg/m2; nutritional, fibre or probiotic supplement use within the previous 4 weeks; current smokers; pregnancy or breastfeeding; chronic or excessive alcohol consumption; unexplained weight loss (>5% body weight) in the past 6 months; diagnosis of chronic disease, including gastrointestinal, metabolic, liver, cardiovascular and respiratory diseases; current use of anti-inflammatory medications (e.g. corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDS)); terminal illness; participation in a research study within previous 4 weeks.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026